Overview

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

Status:
Terminated

Trial end date:
2009-06-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the efficacy and safety of paricalcitol in participants with moderate to severe secondary hyperparathyroidism (SHPT) undergoing hemodialysis who are resistant to treatment with calcitriol.

Phase:

Phase 4

Details

Lead Sponsor:

Abbott

Collaborator:

Statistika Consultoria Ltda

Treatments:

Calcitriol
Ergocalciferols